{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:10:31Z","timestamp":1787242231583,"version":"build-2736575974"},"reference-count":18,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/publications.ersnet.org\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2025,1,12]]},"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1183\/13993003.00044-2025","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:30:15Z","timestamp":1743658215000},"page":"2500044","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Who really responds to asthma biologics? The clue lies in the journey before treatment"],"prefix":"10.1183","volume":"65","author":[{"given":"Freda","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0494-2690","authenticated-orcid":false,"given":"Apostolos","family":"Bossios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,4,3]]},"reference":[{"key":"2025040302300608000_65.4.2500044.1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1186\/s12890-022-02241-2","article-title":"\u2018Life-changing\u2019: the experience of super-responders to biologics in severe asthma","volume":"22","author":"Lanario","year":"2022","journal-title":"BMC Pulm Med"},{"key":"2025040302300608000_65.4.2500044.2","doi-asserted-by":"publisher","DOI":"10.1038\/nri3786"},{"key":"2025040302300608000_65.4.2500044.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200701-085OC"},{"key":"2025040302300608000_65.4.2500044.4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60988-X"},{"key":"2025040302300608000_65.4.2500044.5","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0238-2023"},{"key":"2025040302300608000_65.4.2500044.6","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1016\/j.jaip.2021.06.041","article-title":"Defining a severe asthma super-responder: findings from a Delphi process","volume":"9","author":"Upham","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025040302300608000_65.4.2500044.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02583-2021"},{"key":"2025040302300608000_65.4.2500044.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.10.046"},{"key":"2025040302300608000_65.4.2500044.9","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/all.15867","article-title":"Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients","volume":"79","author":"Thomas","year":"2024","journal-title":"Allergy"},{"key":"2025040302300608000_65.4.2500044.10","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00819-2023"},{"key":"2025040302300608000_65.4.2500044.11","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01497-2024"},{"key":"2025040302300608000_65.4.2500044.12","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1016\/j.jaip.2024.04.026","article-title":"Multivariate cluster analyses to characterize asthma heterogeneity and benralizumab responsiveness","volume":"12","author":"Li","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2025040302300608000_65.4.2500044.13","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00024-2015"},{"key":"2025040302300608000_65.4.2500044.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2003.10.041"},{"key":"2025040302300608000_65.4.2500044.15","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2024"},{"key":"2025040302300608000_65.4.2500044.16","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaci.2019.03.013","article-title":"Stratification of asthma phenotypes by airway proteomic signatures","volume":"144","author":"Schofield","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"2025040302300608000_65.4.2500044.17","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.202301-0149OC","article-title":"Eosinophil subtypes in adults with asthma and adults with chronic obstructive pulmonary disease","volume":"208","author":"Cabrera L\u00f3pez","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2025040302300608000_65.4.2500044.18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01619-2023"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00044-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T05:30:32Z","timestamp":1743658232000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00044-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,3]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1183\/13993003.00044-2025"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00044-2025","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}